Levamisole effect in children with frequently relapsing or steroid-dependent idiopathic nephrotic syndrome

Abolhassan Seyedzadeh; Bita Alimrdani; Akram Soleimani

Journal of Kermanshah University of Medical Sciences

Peer-reviewed Medical Quarterly

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

Authors Guide Submit Manuscript

Levamisole effect in children with frequently relapsing or steroid-dependent idiopathic nephrotic syndrome

Author(s):

Abolhassan Seyedzadeh^1,*,

Bita Alimrdani¹,

Akram Soleimani¹

1Urology and Nephrology Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Kermanshah University of Medical Sciences:Vol. 17, issue 1; e77139

Published online:Apr 29, 2013

Article type:Research Article

Received:Jun 07, 2012

Accepted:Dec 11, 2012

How to Cite:Abolhassan SeyedzadehBita AlimrdaniAkram SoleimaniLevamisole effect in children with frequently relapsing or steroid-dependent idiopathic nephrotic syndrome.J Kermanshah Univ Med Sci.17(1):e77139.

Abstract

Background: Idiopathic nephrotic syndrome of childhood often is could lead to frequent relapses or steroid dependency. Levamisole has been used for this purpose in recent years. But its short and long-term efficacy is still under investigation. This study was done to evaluate the effects of levamisole in idiopathic nephrotic syndrome among children.

Methods: 20 children (11 boys, 9 girls, mean age 6.3+3.3 years) with steroid dependency or frequent relapses were included in the study. After induction of remission with prednisolone 60 mg/m2/day, levamisole was added in a dose of 2.5mg/kg on alternate days while prednisolone dose was reduced to 40 mg/m2/every other day. Then prednisolone was gradually tapered and discontinued. Then the relapse rate and the total cumulative dose of prednisolone before and during levamisole therapy were compared.

Results: The duration of levamisole therapy was 25±18.5 months. The relapse rate was 2.43±0.98/y before and 0.73±0.78/y during levamisole therapy .The difference was statistically significant (P<0.0001). The cumulative steroid dose was 513±192 mg/m2/months before levamisole which was reduced to 292±101 mg/m2/months following levamisole introduction (P<0.0001). Levamisole was effective in15 (75%) patients. No side effect was reported during levamisole therapy.

Conclusion: levamisole is efficacious in managing steroid-dependent frequent-relapsing idiopathic nephrotic syndrome of childhood and long-term relapse-free periods may be expected.

Keywords

Fulltext

References

1.
The references of this article is available on PDF.

comments